Pharmaceutical Information |
Drug Name |
Encorafenib |
Drug ID |
BADD_D02552 |
Description |
Encorafenib, also known as _BRAFTOVI_, is a kinase inhibitor. Encorafenib inhibits BRAF gene, which encodes for B-raf protein, which is a proto-oncogene involved in various genetic mutations [FDA label]. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which impacts cell division, differentiation, and secretion. Mutations in this gene, most frequently the V600E mutation, are the most commonly identified cancer-causing mutations in melanoma, and have been isolated in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of the lung [L3344].
On June 27, 2018, the Food and Drug Administration approved encorafenib and [Binimetinib] (BRAFTOVI and MEKTOVI, Array BioPharma Inc.) in combination for patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test [FDA label]. |
Indications and Usage |
Used in combination with [Binimetinib] in metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test [L3335]. |
Marketing Status |
approved; investigational |
ATC Code |
L01EC03 |
DrugBank ID |
DB11718
|
KEGG ID |
D11053
|
MeSH ID |
C000601108
|
PubChem ID |
50922675
|
TTD Drug ID |
D0TK7R
|
NDC Product Code |
59651-641; 11014-0345; 62009-1913; 54893-0114; 70255-025; 11014-0344 |
UNII |
8L7891MRB6
|
Synonyms |
encorafenib | LGX818 | Braftovi |
|
Chemical Information |
Molecular Formula |
C22H27ClFN7O4S |
CAS Registry Number |
1269440-17-6 |
SMILES |
CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|